Jefferies Financial Group’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.6M | Buy |
162,996
+84,188
| +107% | +$3.41M | 0.06% | 161 |
|
|
2025
Q1 | $4.05M | Sell |
78,808
-341,950
| -81% | -$17.6M | 0.04% | 265 |
|
|
2024
Q4 | $23.3M | Hold |
420,758
| – | – | 0.14% | 68 |
|
|
2024
Q3 | $13.8M | Hold |
420,758
| – | – | 0.1% | 72 |
|
|
2024
Q2 | $11.4M | Buy |
420,758
+150,000
| +55% | +$4.08M | 0.12% | 83 |
|
|
2024
Q1 | $9.84M | Sell |
270,758
-110,000
| -29% | -$4M | 0.09% | 101 |
|
|
2023
Q4 | $7.71M | Buy |
380,758
+50,000
| +15% | +$1.01M | 0.05% | 158 |
|
|
2023
Q3 | $5.88M | Sell |
330,758
-25,000
| -7% | -$444K | 0.05% | 153 |
|
|
2023
Q2 | $6.43M | Sell |
355,758
-90,000
| -20% | -$1.63M | 0.06% | 158 |
|
|
2023
Q1 | $5.6M | Hold |
445,758
| – | – | 0.05% | 163 |
|
|
2022
Q4 | $6.53M | Buy |
+445,758
| New | +$6.53M | 0.05% | 148 |
|